# Rivastigmine Tartrate

NDC: 71209-014
Generic name: Rivastigmine Tartrate
Labeler / Manufacturer: Cadila Pharmaceuticals Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20140211

FDA application: ANDA203844

## Active ingredients

- RIVASTIGMINE TARTRATE: 4.5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"71209-014"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=71209-014
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e7e641fe-39bd-4681-a430-6dedeb6d6af5